REATA PHARMACEUTICALS INC-A (RETA) Stock Income Statement
NASDAQ:RETA - Nasdaq - US75615P1030 - Common Stock - Currency: USD
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.48M | 2.22M | 11.49M | 9.02M | 26.52M | |||
| Cost Of Goods | N/A | N/A | 0.00 | N/A | 124.40M | |||
| Gross Profit | N/A | N/A | 11.49M | N/A | -97.88M | |||
| Operating Expenses | 364.30M | 280.25M | 256.20M | 235.34M | 187.34M | |||
| Research and Development | 203.31M | 169.84M | 155.99M | 159.08M | 128.11M | |||
| Selling, General, and Administrative Expenses | 159.87M | 109.28M | 99.00M | 75.13M | 58.30M | |||
| Operating Income | -341.67M | -278.03M | -244.71M | -226.33M | -285.22M | |||
| Interest Income/Expense | 11.19M | 5.99M | -6.39M | -12.13M | -4.95M | |||
| Other Income/Expense | -37.58M | -41.98M | -46.74M | -21.89M | 10.00K | |||
| Non Recurring Items | N/A | 2.10M | 0.00 | -9.90M | 0.00 | |||
| Income Before Taxes | -87.68M | -311.93M | -297.84M | -270.24M | -290.16M | |||
| Income Tax | -55.00K | -25.00K | -450.00K | -290.00K | 10.00K | |||
| Net Income | -87.62M | -311.90M | -297.39M | -247.75M | -290.17M | |||
| EBITDA | -340.54M | -276.90M | -243.50M | -225.19M | -284.29M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.99 | -8.54 | -8.19 | -7.34 | -9.54 | |||
| Non GAAP EPS | -2.98 | -8.54 | -8.18 | -6.98 | -5.03 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | 100.00% | N/A | -369.08% | |||
| Profit Margin | -373.17% | -14074.95% | -2588.22% | -2746.67% | -1094.16% | |||
| Operating Profit Margin | -1455.08% | -12546.66% | -2129.75% | -2509.20% | -1075.49% | |||
All data in USD